Further studies on the enhancing factor and its possible mechanism of action
- 1 April 1986
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 127 (1), 183-188
- https://doi.org/10.1002/jcp.1041270122
Abstract
In this study the nature of binding of enhancing factor (EF) and its mode of action are examined. EF binds to A431 cells through its own receptor, which is distinct from the receptor for epidermal growth factor (EGF). EF binds to the cell membrane and in turn provides a binding site for EGF. Data analyzed from Scatchard plots show that prior treatment of formalin‐fixed A431 cells with EF for 30 minutes results in an increase in the number of binding sites for 125I‐EGF. 3H‐Thymidine incorporation studies, using the EGF‐receptorless cell line NR‐6, indicate that neither EF nor EGF alone stimulates the cells to synthesise DNA, but when both are added together the cells show 3H‐thymidine incorporation. The role of EF may be to trap EGF and make it available to the cells through its own receptors even in the absence of EGF receptors. EF also induces anchorage‐independent growth of normal fibroblasts in soft agar only in the presence of EGF.This publication has 27 references indexed in Scilit:
- Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblastsCell, 1984
- Purification and properties of a type .beta. transforming growth factor from bovine kidneyBiochemistry, 1983
- Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptorsJournal of Cellular Physiology, 1983
- Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.The Journal of cell biology, 1983
- Effect of retinoic acid and 12-O-tetradecanoyl phorbol-13-acetate on the binding of epidermal growth factor to its cellular receptorsBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factorJournal of Cellular Physiology, 1982
- Platelet-derived growth factor increases prostaglandin production and decreases epidermal growth factor receptors in human osteosarcoma cellsLife Sciences, 1982
- Retinoids specifically enhance the number of epidermal growth factor receptorsNature, 1980
- Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptorsNature, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970